Study Examines Safety of Immune Checkpoint Inhibitor Therapy in Patients With HIV
Source: Cancer Network, March 2019
No new safety or efficacy concerns were found for advanced-stage cancer patients with HIV infection who received immune checkpoint inhibitor therapy, a systematic review published in JAMA Oncologyreported. However, since the conclusions rely largely on case reports, prospective studies are needed before the safety of immune checkpoint inhibitors in cancer patients with HIV can be fully known.
To investigate the safety and efficacy of immune checkpoint inhibitors in cancer patients with HIV, the study researchers performed a literature review and identified 13 articles (11 case reports and 2 retrospective case series) for analysis. They also reviewed the annual meeting proceedings from major oncology society conferences and found 4 meeting abstracts for analysis.